Episode 20: Mysteries within Enigmas: Answering Listener Mail
In our 20th episode we try to answer our accumulating listener mail. We review questions around cardiovascular disease risk-benefits and try to demystify the calculators. Listeners question antidepressants: when they should start to work, when to change dose/type and their use for chronic pain. Other issues include stopping bisphosphonates, addressing the placebo effect and uncertainties with industry funded trials. In the end, Mike talks about Giraffes and James becomes spastic.
Show Notes
1) Meta-analysis data for mortality benefit with statins in primary prevention
TI meta-analysis on statins in women for primary prevention.
“For women without cardiovascular disease, lipid lowering does not affect total or CHD mortality. Lipid lowering may reduce CHD events, but current evidence is insufficient to determine this conclusively.”
2) Don’t change the doses of antidepressants too quickly
3) How quickly do antidepressants work?
Arch Gen Psyc 2006; 63: 1217-23. (for how fast anti-depressants work)
4) How long do we use bisphosphonates?
N Engl J Med 2004;350:1189–1199
Listening to this episode is for premium podcast members only. If you already have a membership, login to your account. If you aren't yet a premium subscriber, sign up today!
